The industry shaping agenda

16 learning modules · 32+ hours of content · Interactive Q&A, workshops and roundtables

We are reinventing the event format rule book to maximize your time and elevate your learning experience. The agenda is designed as learning modules, with 2 hour segments of thematically-linked case studies and panels spread out so you can easily block out the time for the modules relevant to you

C-Suite keynotes - Shape health: Pharma's new role in the healthcare paradigm

9:00am – 9:20am (EST)

Collaborate together to win together

  • Embrace competitive collaboration and soar to new heights of innovative value creation for patients
  • Partner with healthcare stakeholders to create a world ready for this decade of unprecedented scientific innovation

John Young Group President, Chief Business Officer Pfizer

9:20am – 10:00am (EST)

Create the new healthcare system of the future

  • Discard the broken healthcare model of today and develop a new Pharma-Payer-Provider relationship, with stakeholders working in tandem to drive greater patient outcomes
  • Futureproof the US healthcare system to encourage innovation and improve access to novel treatments of the future
  • Put patients at the centre of a new system by collaborating with payers and regulators to expand pathways to quality care

Kabir Nath President and CEO Otsuka North America

Dave Lennon President Novartis Gene Therapies Novartis

Myrtle Potter CEO Sumitovant Biopharma

10:00am – 10:20am (EST)

Turn Vaccines into vaccinations. Pharma’s role in fighting misinformation

  • Lead the fight against misinformation to deliver fast and effective vaccines across the world
  • Reduce disparities in vaccine effectiveness by working closely with patient communities

Elaine O’Hara Chief Commercial Officer North America Sanofi Pasteur

10:20am – 10:40am (EST)

Win with purpose: why your future blockbusters won’t be defined by a molecule

  • Stay true to your calling: ensure you serve the right patient at the right time, and transcend drug efficacy as the key factor in delivering outcomes.
  • Examine the capabilities, processes, and technologies needed to build a business model which cuts down the time from disease onset to cure.
  • Stick to your roots: move beyond lip-service and ensure a more comprehensive understanding of patients and how you can make significant improvements in engaging and gathering insights.

Jaswinder Chadha CEO and President Axtria

10:40am – 11:00am (EST)

How a diverse leadership team has delivered new levels of value

  • See the business case for diversity across senior leadership positions
  • Explore new solutions to pharma’s age old problems through blending different experiences and backgrounds into a new strategy fit for 2021

Deborah Waterhouse Chief Executive Officer ViiV Healthcare

11:00am – 11:20am (EST)

BREAK

C-Suite keynotes - The new era of pharma innovation

11:20am – 11:30am (EST)

3 is not a crowd: pharma’s role in enhancing the doctor-patient relationship

  • Understand the journey of the patient – doctor relationship in disease treatment.
  • How Life Science companies can enhance, enable and empower better outcomes for patients, clinicians and partners throughout the care journey.

Angelo Campano Senior Vice President and Principal, Agency Channels OptimizeRX

Michael Parisi CEO Guidemark Health

12:00pm – 12:20pm (EST)

The hybrid field force of the future

  • Move from a digital-first to customer-first engagement model through a hybrid, tech-enabled approach
  • Empower your team to better serve the customer by uniting field, digital, IT and commercial behind one omnichannel strategy
  • Build a culture of agility and continuous improvement to enhance your ability to adapt to local challenges and opportunities

Teresa Bitetti President Global Oncology Business Unit Takeda

12:20pm – 12:40pm (EST)

Futureproof your business model through effective change management frameworks

  • Discover the roles and functions of tomorrow that will keep you competitive throughout the industry’s evolution
  • Effectively communicate new ways of working to drive efficiencies and empower your teams for success

Keren Haruvi President and Head of North America Sandoz

12:40am – 1:00pm (EST)

Unlock unprecedented patient value through gene editing technology

  • See how collaboration across the industry can supercharge innovation
  • Learn how CRISPR’s technology can launch a new era of medicine

Samarth Kulkarni CEO CRISPR Therapeutics

1:00pm – 1:20pm (EST)

Mission Possible - how Pfizer and Nat Geo worked together to tell the story of Pfizer's COVID vaccine

More details to come

Sally Susman Chief Corporate Affairs Officer Pfizer

Michael Wiese SVP Branded Content, National Geographic Partners and Head of Nat Geo CreativeWorks National Geographic

1:20pm – 1:40pm (EST)

Reuters News led interview

Caroline Humer Correspondent Reuters

Rick Gates SVP, Pharmacy and Healthcare Walgreens

Pharma Only
Market Access and RWE:
Workshop

2:00pm – 3:00pm (EST)

Using RWE to drive next-level commercial impact

  • Connect clinical trial data with clinical, claims, and lab data to strengthen market access
  • Use SDoH-decorated patient journeys to boost commercial strategy
  • Turn real-world insights into value to achieve business growth

Manisha Shetty Gulati Chief Operating Officer Clarify Health

Paul Petraro Global Head, RWE Analytics Center of Excellence (CoE) Boehringer Ingelheim

Pharma Only
Marketing and Commercial:
Workshop

3:00pm – 4:00pm (EST)

MedStorm: The Ingenuity Summit

  • Learn new strategies to enhance your brands potential for improving patient care and draw on the brain power of industry executives
  • Address public health crises topics such as obesity, diabetes, pain management, and other health issues
  • ‘MedStorm’ ideas and suggestions to set a new best practice for healthcare marketing as well as medical KOL’s

Vince Parry Executive Vice President Brand Strategy Truth Serum

Mission: Maintain digital momentum

10:00am – 10:45am (EST)

From reactive to proactive: direct the future of digital transformation

  • Move fast without breaking things - effectively implement change management at scale for transformation without customer experience disruption
  • Achieve personalized HCP engagement by leveraging new data sources and advanced analytics to create more actionable insights for commercial decision-making
  • Forge more authentic relationships with patients and HCP’s with complex behavioral understanding and customer-profiling
  • Create a culture of continuous digital progression by optimizing performance metrics for new hybrid strategies and reimagining traditional training & development programs

Erik Janssen Vice President Digital Business Transformation Immunology UCB

Laurie Meyers Head of CMG Patient Engagement Genentech

Julien Pahud International Customer Analytics & Digital Health Leader Eli Lilly

Moderator: Melinda Decker Chief Commercial Officer MyMee

10:45am – 11:00am (EST)

Become a technology leader

  • Embed an agile, digital-first culture across all elements of your commercial function by recalibrating role responsibilities and modernizing training programs
  • Break down internal siloes across commercial to combine insights and create a 360-degree understanding of HCP’s needs and behaviors
  • Pool expertise, bring specialists and research teams into marketing processes, and look outside our industry for digital inspiration to enrich interactions

Saskia Steinacker Global Head IT Strategy & Digital Transformation Bayer

11:00am – 11:15am (EST)

Adapt to evolving patient needs by reimaging cross-functional collaboration

  • Collaborate to innovate – how to work alongside medical affairs, market access and patient engagement teams to develop more complete insights and Create a holistic engagement strategy
  • Same objectives, different delivery: Educate and empower patients by use advanced analytics to better target and personalize communications
  • How to track performance across your organization to simplify the patient journey and demonstrate value beyond traditional commercial measures

Delphine Dubois, MD Chief Innovation Officer Healthcare Consultancy Group

Greg Imber Chief Engagement Officer Healthcare Consultancy Group

11:15am – 11:30am (EST)

Leverage innovation to flourish as we transition to a post COVID-landscape

  • How to bring an innovative approach to digital marketing, sales, and how to interact across the healthcare spectrum
  • Outline the evolved role of the sales rep and increase efficiency through skills onboarding and training to meet the new needs of the marketplace
  • Examples of how this new techniques have been successfully implemented

Pablo Alvarez President and General Manager USA Almirall

11:30am – 11:45am (EST)

The evolution of the virtual go-to-market model for innovative medicines

Zhen Su Senior Vice President Head of Global Oncology Business Franchise EMD Serono

11:45am – 12:00am (EST)

Live Q&A - Mission: Maintain digital momentum

Saskia Steinacker Global Head IT Strategy & Digital Transformation Bayer

Pablo Alvarez President and General Manager USA Almirall

Zhen Su Senior Vice President Head of Global Oncology Business Franchise EMD Serono

Delphine Dubois

Gregory Imber

Secure Medical influence, drive decision-making and value

12:00pm – 1:00pm (EST)

Behind the pharma steering wheel: Lead cross-functional strategy in the new era of healthcare innovation

  • Review how Medical Affairs can lead the optimization of new cross-functional processes to drive efficiencies and increase customer value
  • Improve HCP and patient experiences by unify cross-company customer objectives – how to overcome cultural differences to better partner and manage change
  • Explore new skillsets, capabilities and compliance frameworks needed to facilitate the growth of internal influence

Kirk Taylor, MD Senior Vice President, Regional Medical Affairs, North America EMD Serono

Omar Perez Head of Medical Diagnostic Strategy AstraZeneca

Parambir Bhangu Medical Affairs Lead, Canada (currently appointed for Organon & Co.) Merck

1:00pm – 1:15pm (EST)

Inform external policy to improve patients’ lives

  • How to ensure science and patient outcomes are at the center of external policy efforts
  • Case study: Learn how Pfizer’s Medical Affairs team has informed and impacted external anti-microbial resistance (AMR) policy efforts
  • Ensure that your companies policy efforts are aligned across functions and that the Medical Affairs voice is heard

Pol Vandenbroucke Senior Vice President, Chief Medical Officer, Hospital Business Unit Pfizer

1:15pm – 1:30pm (EST)

Measure and optimize Medical Affairs strategy with Share of Scientific Voice™

Description tbc

David Kelaher Chief Medical Officer PharmaSpectra

1:30pm – 1:45pm (EST)

Elevate medical authority and deliver new, stakeholder-centric value

  • Hear how Viiv’s model of strategic Medical Affairs independence has successfully delivered better insights and outcomes
  • Become the trusted partner for information exchange with physicians across a multi-channel strategy
  • Embody the voice of both patients and physicians to drive an agile, customer-centric company strategy

Harmony Garges Chief Medical Officer ViiV Healthcare

1:45pm – 2:00pm (EST)

Live Q&A - Secure Medical influence, drive decision-making and value

Pol Vandenbroucke Senior Vice President, Chief Medical Officer, Hospital Business Unit Pfizer

Harmony Garges Chief Medical Officer ViiV Healthcare

Drive permanent patient-centric change through novel collaboration

2:00pm – 3:00pm (EST)

Real patient-centric transformation means real cross-industry collaboration

  • Cut the crap! Simplify the patient experience by working with your competitors to reduce overlap in apps, support programmes, and other services
  • How to create collaboration frameworks that enable greater interoperability while working within FDA guidelines
  • Fulfil business imperatives by demonstrating positive long-term patient outcomes and experience measures with new real-world insight

Eric Kinariwala Founder/Chief Executive Officer Capsule

Fatima Scipione Head of Oncology Patient Advocacy Takeda Oncology

Alicia Staley Senior Director Patient Engagement Medidata

Kristen Huehbner Associate Director Engagement Strategy Bristol Myers-Squibb

Moderator: Maimah Karmo Founder/Chief Executive Officer Tigerlily Foundation

3:00pm – 3:15pm (EST)

Thoughtful Connections: Becoming more human in how we engage patients

  • Tackle the disproportionate impact of COVID-19 on underserved populations, especially in cancer treatment
  • Identify the key underlying challenges to the racial and generational barriers in healthcare and oncology
  • Build trust in the healthcare system and overcome race-related bias within the health ecosystem

Michael Petroutsas Senior Vice President US Oncology Business Unit GlaxoSmithKline

3:15pm – 3:30pm (EST)

Thought leadership opportunity available

3:30pm – 3:45pm (EST)

Enabling faster, more representative patient engagement and turn insights into action

  • Engage patients to inform product and trial design for enhanced drug development. Move from ad hoc engagements to the systematic integration of patient insights across the development continuum
  • Establish legal and compliant processes that enable agile integration of insights across the organization
  • Strategically collaborate with patient and professional societies, and other patient engagement organizations, to ensure diverse and representative insights are seamlessly integrated into clinical development programs

Hilary Wilson Director of Patient Affairs and Engagement Boehringer Ingelheim

3:45pm – 4:00pm (EST)

Live Q&A - Drive permanent patient-centric change through novel collaboration

Michael Petroutsas Senior Vice President US Oncology Business Unit GlaxoSmithKline

Hilary Wilson Director of Patient Affairs and Engagement Boehringer Ingelheim

Pharma Only
Marketing and Commercial:
Workshop

4:00pm – 5:00pm (EST)

Building a modular content system for your pharma brand: Where to begin?

  • Identify which assets are best suited for modular content and where and how the MLR fits in the process
  • Build a business case to get buy-in from stakeholders
  • Know what to ask when selecting a modular content partner
  • Enable an effective change management strategy

Robb DeFilippis Managing Director Life Sciences TAG

Jeremy Richter Director Regulatory Affairs Life Sciences TAG

Stephanie Lee-Pang Head of Operations Life Sciences TAG

Dax Alexander Senior Director Client Engagement Life Sciences TAG

Patient Engagement:
Networking

4:00pm – 5:00pm (EST)

Connection Hour for Patient Engagement

Unpack the learnings of the day and make meaningful connections with Patient Engagement leaders from across Pharma USA - feel free to bring questions for speakers, conversation prompts you're dying to discuss or just yourself.

Hone Medical engagement for the evolved stakeholder landscape

10:00am – 11:00am (EST)

Healthcare’s new experts? Prioritize patient outreach in 2021

  • Analyze recent shifts in HCP authority as patient-clinical engagement has decreased throughout the pandemic
  • Leverage Medical expertise to drive company education strategies that champion accurate science and value patients’ lived experiences
  • Center the emancipated patient journey in cross-functional workstreams to effectively engage patient organizations and support recruitment for activities

Sonal Bhatia Rare Disease Chief Medical Officer Pfizer

Doug Stover Vice President, Global Head of Innovation Alexion Therapeutics

Julie Ferrante Senior Customer Success Manager Komodo Health

Hisham Farouk International Respiratory & Immunology Medical Director AstraZeneca

11:00am – 11:15am (EST)

Take the lead: Center Medical Affairs expertise in multi-stakeholder engagement

  • Emphasize the importance of scientific credibility to increase value and gain cross-functional influence and engagement among customer-facing and internal teams
  • Center clinical risk/benefit equation in every external stakeholder conversation to build a communications culture that is truly patient-oriented, science-grounded and appropriately adapted for each audience’s level of medical knowledge
  • Lead through influence in whole-company communications strategy to foster greater awareness of treatment pathways and instil trust among the public

Craig Granowitz Senior Vice President Chief Medical Officer Amarin Pharma

11:15am – 11:30am (EST)

The new peer review: Why digital platforms for HCP communication represent an important shift in the influence paradigm

  • Examine where, how, and why HCPs are congregating online, and how this creates new sources of customer insight
  • Understand the current limitations and realistic promise of these platforms
  • Adapt your medical communications and evidence-dissemination strategy to account for the implications of this paradigm shift

Solomon Banjo Managing Director, Lifesciences and Ecosystem Research Advisory Board

11:30am – 11:45am (EST)

HCPs are the new KOLs: Harness expertise in fast-moving settings

  • Adjust your assessment of key KOL attributes in today’s volatile health landscape
  • Engage a broad range of HCPs in strategic planning to attain timely responses to evolving medical guidance
  • Set algorithms that prioritize attributes other than academic publication history to identify the most relevant HCPs for KOL insights, including Digital Opinion leaders

Eddie Power Vice President North America Medical Affairs Pfizer

11:45am – 12:00pm (EST)

Live Q&A - Hone Medical engagement for the evolved stakeholder landscape

Craig Granowitz Senior Vice President Chief Medical Officer Amarin Pharma

Solomon Banjo Managing Director, Lifesciences and Ecosystem Research Advisory Board

Eddie Power Vice President North America Medical Affairs Pfizer

Transform commercial strategy with AI

12:00pm – 1:00pm (EST)

Leverage conversational AI to deliver predictive support in times of customer uncertainty

  • Use machine learning to operate more proactively by anticipating physician needs and planning “Next Best Action” engagement strategies
  • Inform targeting strategy and track performance by turning varied and complex data sets into varied and complex customer insights through AI-led customer profiling systems

Lawrence Bressler Head Global Value (Marketing) and Market Access- Rare Disease Business Unit Chiesi

Leo Petrossian Chief Executive Officer Nile

Nathan Treloar President and Co-Founder Orbita

12:50pm – 1:05pm (EST)

Achieve rapid customer response times that don’t skimp on quality through new advances in automation

  • Optimize your AI-based response systems to more acutely consider compliance and regulations to expand communication options
  • Balance the need for ambitious personalized communications with regulatory obligations
  • Combine human oversight with AI-driven observation to improve marketing outcomes

    VOLV Global

1:05pm – 1:20pm (EST)

Add value at every customer touchpoint with fully contextualized decision-making

  • Take a holistic view across your customer’s whole journey to remove disjointed communications and ensure high quality engagements
  • Finetune your internal tech stack with a CRM system optimized to meet customers needs
  • Effectively implement omnichannel strategy with new cross-functional collaboration frameworks that unlock all available insights and ensure channel interoperability

Andy Kennemer Vice President Customer Experience and Digital Innovation GlaxoSmithKline

1:20pm – 1:35pm (EST)

Digital Transformation and a futurist vision in HealthTech

  • How to define digital transformation correctly in a rapid-paced environment
  • Identify the industry disruption and what lies ahead for pharma marketers

Rahul Avasthy Head Digital Transformation and Experience Abbott Laboratories

1:35pm – 1:50pm (EST)

Innovation by Disruption: Shattering the Siloes

Continued innovation leadership in Pharmaceuticals and Biotech requires breaking down traditional boundaries between R&D and Commercial functions. At Janssen, integrated teams partner on strategies “from HTL to LOE.” This seamless relationship enables teams to make better portfolio choices and maximize impact for patients, healthcare providers, and payers.

Teri Lawver Global Vice President, Immunology, Global Commercial Strategy Leader, Janssen Pharmaceuticals Johnson & Johnson

1:50pm – 2:00pm (EST)

Live Q&A - Transform commercial strategy

Andy Kennemer Vice President Customer Experience and Digital Innovation GlaxoSmithKline

Rahul Avasthy Head Digital Transformation and Experience Abbott Laboratories

Teri Lawver Global Vice President, Immunology, Global Commercial Strategy Leader, Janssen Pharmaceuticals Johnson & Johnson

    VOLV Global

Deliver on fair pricing and access: Innovate out of disruption

2:00pm – 3:00pm (EST)

Innovation for life, not just for COVID: Make healthcare affordable

  • Review the role of unprecedented government funding in R&D and advanced market commitments – plus what it means for subsequent investment
  • How the Biden administration may impact pricing innovation and what downstream consequences of affordable care policies may be
  • Dissect the impact of recent Emergency Use Authorizations (EUAs) on future evidence requirements

Chris Leibman Senior Vice President Value and Access Biogen

Sarah Emond Executive Vice President ICER

Robert Dubois President & Chief Executive Officer National Pharmaceutical Council

3:00pm – 3:15pm (EST)

Thought leadership opportunity available

3:15pm – 3:30pm (EST)

How to create a breakthrough patient-centric digital program with REMS

  • Understand how to create a patient-centric interactive program to support REMS (Risk Evaluation and Management Strategy) requirements
  • Learn how to navigate the necessary cross-functional collaboration to ensure success
  • Uncover the lessons learned in the implementation and execution of a digital program

Surbhi Pandit-Patel Associate Director, Digital Solutions Patient Support Otsuka

Tom Feitel Global Head, Enterprise Customer Solutions Medocity

3:30pm – 3:45pm (EST)

From volume to value: Deliver for evolved customers post-COVID

  • Tailor product value propositions to Payer and Health Systems’ new definitions of value that include total cost of care, achieving quality metrics, STAR ratings and patient satisfaction
  • Implement an enterprise-focused approach to adapt to the increasing vertical and horizontal integration of customers
  • Deliver additional value in HCP interactions by sharing differentiated insights
  • Embrace a strategic customer-centric approach to align functions and gain deeper actionable knowledge of customer needs

Matt Portch Senior Vice President Sales and Market Access Sunovion

3:45pm – 4:00pm (EST)

Live Q&A: Deliver on fair pricing and access: Innovate out of disruption

Matt Portch Senior Vice President Sales and Market Access Sunovion

    Medocity

    Otsuka

Pharma Only
Marketing and Commercial:
Roundtable

4:00pm – 5:00pm (EST)

Leverage the brain’s predispositions: Scientific storytelling helps engage influencers in your marketing strategy

Solutions that overcome information overload and fragmented audiences are increasingly vital to the success of pharma marketing and medical education efforts. How do you engage healthcare professionals efficiently and help your audiences retain information effectively in this environment of distraction?

This roundtable will highlight ways to go beyond scientific storytelling through more compelling narratives and visual identities. Shared with your audiences through multiple channels, including physician leaders and influencers, these build credibility and establish scientific differentiation for your brand.

A compelling narrative that builds the prerequisite knowledge or mental framework around complex science will more effectively engage your audience—particularly when delivered by trusted peer influencers. These ideas help connect medical communications and marketing needs, and you’ll walk away with new ideas for an effective bridging strategy that can

  • Prepare the market pre-commercialization
  • Identify and bridge educational gaps
  • Highlight competitor vulnerabilities by emphasizing your point of difference
  • Establish familiarity with clinical end points, modes of administration, or therapeutic mechanisms

    MedThink

Market Access and RWE:
Networking

4:00pm – 5:00pm (EST)

Connection Hour for Access, Evidence and RWE

Unpack the learnings of the day and make meaningful connections with Access, Evidence and RWE leaders from across Pharma USA - feel free to bring questions for speakers, conversation prompts you're dying to discuss or just yourself.

Perfect digital performance with complete impact understanding

10:00am – 11:00am (EST)

Prove digital ROI and obtain long term buy-in from boardroom level

  • Capture metrics from personalized communications to accurately predict and present success to internal stakeholders
  • Bring your organization with you on the digital journey through concise expenditure accountability

Christopher Nugent Associate Director Digital Marketing & Strategy Alkermes

Sai Rangarao Vice President and Head of Marketing BioDelivery Sciences International

Jack Barrette Chief Executive Officer WEGO Health

Orchid Jahanshahi Vice President Commercial, Life Sciences ODAIA

11:00am – 11:15am (EST)

Enhance customer profiling and measure what matters to deliver marketing success

  • Objectives and key results to identify when measuring engagement
  • Utilize OKR’s to help produce long term marketing results
  • Link corporate objectives to OKR’s and place marketing at the heart of the boardroom’s thoughts

Vinicius Castro Digital Product Director - Web GlaxoSmithKline

11:15am – 11:30am (EST)

Find balance between your internal capabilities and the integration of agencies and external partners

  • Objectives and key results to identify when measuring engagement
  • Utilize OKR’s to help produce long term marketing results
  • Link corporate objectives to OKR’s and place marketing at the heart of the boardroom’s thoughts

    Medallia

11:30am – 11:45am (EST)

Maximize the digital marketing experience with a test and learn mindset

  • Define marketing objectives and successfully roadmap your strategy
  • Install a hypothesis-based approach to all your marketing projects
  • Iterate, scale or abandon: How to successfully leverage data-driven insights

Brett Marvel Associate Director Digital Engagement Merck

11:45am – 12:00pm (EST)

Live Q&A - Perfect digital performance with complete impact understanding

Vinicius Castro Digital Product Director - Web GlaxoSmithKline

Brett Marvel Associate Director Digital Engagement Merck

    Medallia

Create the next-gen MSL

12:00pm – 1:00pm (EST)

Hot for hybrid: Building Medical’s field teams for healthcare’s new normal

  • Review the implications of new field force models on the structure of Medical Affairs and capability needs – plus how to ensure future resource needs are secured
  • Explore new digital skillsets and flexible engagement frameworks needed to ensure MSL success in hybrid operating models
  • How MSLs can collaborate with counterparts in diagnostics and sales roles to meet emerging stakeholder needs
  • Optimize change management strategy to support teams’ adaption to new operational models

Jefferson Tea Vice President Medical & Scientific Affairs Takeda

Suzanne Giordano Head of Field Medical Sunovion

1:00pm – 1:15pm (EST)

Upskill your connectors: Prime MSLs for success in the digital age

  • Increase engagement volume through new digital channels – how to identify and resolve skills gaps to build MSL capability in virtual settings
  • Invest in improved written communications skills to enhance opportunities for meaningful engagement
  • Strategically prioritize and pace the dissemination of insights among stakeholders to maximize demonstration of value

1:15pm – 1:30pm (EST)

From virtual to hybrid engagement: Medical field team trends

  • Understand best-practice for the array of virtual engagement options available and the benefits of each
  • Achieve holistic engagement through a field team strategy that balances both digital and F2F interactions based on HCP need
  • What the pace of innovation in virtual interaction means for MSLs in the future

Lance Hill CEO Within3

1:30pm – 1:45pm (EST)

Optimize cross-field force collaboration to support improved health outcomes

  • Take a holistic view of cross-Medical field force strategy to improve liaison skillsets and efficiencies in hybrid and virtual settings
  • Support compliant collaboration between field liaison teams to expand long-term relationship development across the healthcare system
  • Convert team processes from individual reach-out to coordinated key account management (KAM) to better respond to wider customer and company needs

Donna Booth Director, Field Medical HTA & Policy GlaxoSmithKline

1:45pm – 2:00pm (EST)

Live Q&A - Create the next-gen MSL

Donna Booth Director, Field Medical HTA & Policy GlaxoSmithKline

Medical Affairs:
Networking

2:00pm – 3:00pm (EST)

Connection Hour for Medical Affairs

Unpack the learnings of the day and make meaningful connections with Medical Affairs leaders from across Pharma USA - feel free to bring questions for speakers, conversation prompts you're dying to discuss or just yourself.

Novel patient support programmes true to patient need

10:00am – 11:00am (EST)

Beyond treatments - commit to survivorship and caregiver support to deliver long-term value

  • Improve outcomes by developing physician and caregiver capabilities through dedicated support programmes
  • Perform environmental analysis to uncover support gaps across the entire patient journey
  • Demonstrate the commercial benefit of non-patient focused patient support

    Medisafe

Kimberly Irvine Founder and Chief Executive Officer KGI Health

Barbara Collura President and CEO RESOLVE: The National Infertility Association

Tyler Marciniak

11:00am – 11:15am (EST)

Embed a patient centric mindset: Introducing the A ‘Patients Like Us’ APAC Toolkit

  • How do we move the needle on patient centricity from a ‘nice to have’ or ‘buzz word’ to one that is truly embedded into the company’s DNA?
  • Why defining the company’s WHY is crucial when connecting to a sense of purpose? We can all describe what we do and how, but do we know WHY we do what we do?
  • How to take patient centricity ‘off the wall and into the hands of our people’ and to make it a tangible reality rather than an abstract concept

Peter Said

11:15am – 11:30am (EST)

Lasting Transformation in Patient Engagement and Adherence in the New Era of Healthcare

  • Understand current state of patient and healthcare provider engagement with the return of in-person interactions
  • Identify lasting innovations of the COVID-19 era, including advanced analytical tools, virtual engagement technologies and primary point of contact models
  • Learn best practices from the industry to maximize engagement by balancing both in-person and virtual interactions, using digital health literacy predictors, and hybrid models, among other solutions

    VMS Biomarketing

11:30am – 11:45am (EST)

Ensure new pandemic driven initiatives improve pre-pandemic health literacy standards

  • Create processes that ensure new, more quickly developed digital content and education efforts maintain patient-friendly language
  • How to work with patients to understand new challenges driven by COVID-19 in patient education and the help prevent misinformation

Margaret Alabi US Patient Advocacy Lead - Immunology Patient Value Unit UCB

11:45am – 12:00pm (EST)

Live Q&A - Novel patient support programmes true to patient need

Peter Said

Margaret Alabi US Patient Advocacy Lead - Immunology Patient Value Unit UCB

Novel Real World Evidence use across the lifecycle

12:00pm – 1:00pm (EST)

Build a holistic RWE strategy to optimize value demonstration and access

  • Identify critical areas of improvement for deriving greater value from RWE/D for valuation and assessment
  • Overcome data linkage challenges to deepen insights and strengthen your position in access negotiations
  • Drive market access success with endpoint strategy in early trial development

Shuvayu Sen Vice President and Head, Global Value and Real World Evidence Otsuka

Paul Petraro Global Head, RWE Analytics Center of Excellence (CoE) Boehringer Ingelheim

Sharon Chen Senior Director, Head of Pipeline Payer & Evidence Strategy, Global Value & Access Biogen

1:00pm – 1:15pm (EST)

Win support for RWE innovation despite pandemic budget cuts

  • Maintain priority for RWE investment that supports cross-functional excellence
  • Impact internal decision-making to enable RWE pioneering that leads to whole-company success
  • Partner with internal and external stakeholders to evaluate company risk-taking effectively

Amanda Bruno Vice President and Head RWE Oncology Bayer

1:15pm – 1:30pm (EST)

Downstream impacts of RWE – from accelerating drug discovery to expediating patient access

  • Explore how the use of RWE in clinical development is blurring the lines between traditional product lifecycle phases
  • Understand opportunities to explore enhanced indications for already approved products
  • Assess artificial intelligence’s impact on RWE and its potential to accelerate patient access to therapies

Scott Swain, PhD, MPH Director, Regulatory Sciences & Real-World Evidence Cardinal Health

1:30pm – 1:45pm (EST)

Unlock collaboration with dispensers through regulatory interoperability

  • Enhance patient outcomes with greater collaboration between manufacturers and dispensers around regulatory compliance
  • Case study: see how XATP, an identity authentication and enhanced verification framework pioneered at UCLA Health with participation from Genentech, Amgen, and Sanofi, heightened verification efficiencies and security
  • Generate RWE insights from the last mile of the supply chain while gaining new tools for dispensers to intercept counterfeit drugs and reduce wastage with interoperability under DSCSA

Ben Taylor CEO LedgerDomain

Ghada Ashkar Director of Ambulatory Pharmacy Services UCLA Health

1:45pm – 2:00pm (EST)

Live Q&A - Novel Real World Evidence use across the lifecycle

Amanda Bruno Vice President and Head RWE Oncology Bayer

Scott Swain, PhD, MPH Director, Regulatory Sciences & Real-World Evidence Cardinal Health

Ben Taylor CEO LedgerDomain

Ghada Ashkar Director of Ambulatory Pharmacy Services UCLA Health

Personalize HCP experiences for deeper engagement

2:00pm – 3:00pm (EST)

Drive customer value in the new digital landscape with personalized experiences

  • Harness AI to inform your sales approach and meet your customers’ need for both human interaction and digital engagement
  • Pull don’t push: Build more meaningful relationships with customers by engaging only when necessary and delivering value-add supporting content
  • Supplement face- to-face interactions with a digital backdrop of integrated channels for an enriched “surround-sound” customer experience

Rusty Rahmer Head of Customer Experience Solutions GlaxoSmithKline

Deepak Tomer Digital Marketing Lead Eli Lilly

Kelli Tea Director Commercial Development Protara

Bill Evans Chief Marketing Officer Komodo Health

Amy Hutnik General Manager, Agency, Advisory and Evidence Services EVERSANA

3:00pm – 3:15pm (EST)

Thought leadership by TrendMD

    TrendMD

3:15pm – 3:30pm (EST)

Retain the human touch in a digital-first era

  • Demand based meaningful touch points and deliver value-based interactions to HCPs
  • Continue the momentum of digital adoption across organizational touchpoints
  • Move to account based marketing and empower the messenger

Deepak Tomer Digital Marketing Lead Eli Lilly

3:30pm – 3:45pm (EST)

Use Advanced Analytics (AI/ML) to maximize HCP Engagement

  • Trigger next best action in real time and personalize your engagement for individual customers
  • Deploy machine learning to find engagements and messages that have the most impact
  • Utilize predictive analytics to identify optimal cadence and frequency of communication

Mike Steward Chief Digital Officer Principal Analytical Wizards

3:45pm – 4:00pm (EST)

Live Q&A - Personalize HCP experiences for deeper engagement

Deepak Tomer Digital Marketing Lead Eli Lilly

Mike Steward Chief Digital Officer Principal Analytical Wizards

    TrendMD

Pharma Only
Market Access and RWE:
Roundtable

4:00pm – 5:00pm (EST)

Supporting digital therapeutic development with RWE

Description tbc

    Medullan

Marketing and Commercial:
Networking

4:00pm – 5:00pm (EST)

Connection Hour for Marketing and Commercial

Unpack the learnings of the day and make meaningful connections with Marketing and Commercial leaders from across Pharma USA - feel free to bring questions for speakers, conversation prompts you're dying to discuss or just yourself.

Heighten Medical value with personalized omnichannel interactions

10:00am – 11:00am (EST)

From aspiration to action: Scale digital transformation in Medical Affairs

  • Tear down siloed operations to minimize cost and outcome inefficiencies, and deliver seamless CX that flows across engagement channels and devices
  • Harmonize data to assemble a single view of the customer, improving reliability of service and speed of response
  • Invest in future-ready insights management systems to drive elevated engagement built on trusted, credible data
  • Blend traditional Medical teams with data and tech colleagues to sustain compliant digital integration

Warren Winkelman Senior Medical Director and Head of Medical Innovation Galderma

Christopher Keenan Head, Worldwide Medical Customer Engagement, Medical Capabilities Bristol-Myers Squibb

Larisa Ramirez International CVRM Medical Director AstraZeneca

11:00am – 11:15am (EST)

Social media: Medical Affairs’ win-win deal to improve HCP engagement

  • Embrace the age of the omnichannel MSL - turbocharge insight generation with social media listening
  • Minimize MSL response timelines to boost HCP education and quicken treatment pathways for patients
  • Shift from reactive to proactive strategy and instigate cross-stakeholder discussion to weather regulatory challenges

Luca Dezzani Franchise Head Immuno-Oncology AstraZeneca

11:15am – 11:30am (EST)

Injecting innovation into Medical Affairs & Publications: Five big ideas to drive HCP engagement

Delphine Dubois, MD Chief Innovation Officer Healthcare Consultancy Group

Greg Imber Chief Engagement Officer Healthcare Consultancy Group

11:30am – 11:45am (EST)

Virtual scientific exchange: Your guide to heightened ROI

  • Maximize ROI with compelling and engaging narratives that successfully communicate data and patient studies in virtual formats
  • Streamline ways of working to beat condensed virtual event timelines and increase thought-leadership opportunities
  • Gain networking best practices to maximize meaningful interactions and optimize lead generation at digital congresses

Chirag Shah, PharmD Head of Strategic Publications & Medical Education Neurocrine Biosciences

11:45am – 12:00pm (EST)

Live Q&A - Heighten Medical value with personalized omnichannel interactions

Luca Dezzani Franchise Head Immuno-Oncology AstraZeneca

Chirag Shah, PharmD Head of Strategic Publications & Medical Education Neurocrine Biosciences

Delphine Dubois, MD Chief Innovation Officer Healthcare Consultancy Group

Greg Imber Chief Engagement Officer Healthcare Consultancy Group

Modernize your field teams and become healthcare partners

12:00pm – 1:00pm (EST)

Move from a field force to hyper-specialized partners for HCP’s

  • Assess a new hybrid sales and marketing model combining sales reps with data-driven support throughout the customer journey
  • Prioritize inbound marketing through digital marketing campaigns to replenish reps’ sales funnels throughout the year
  • Revamp how you engage with practitioners and patients through less frequent, higher quality communications

Mark Schwitzenberg Vice President Marketing Medical Specialties Astellas Pharma

Yvette Leung US Myeloid Marketing Bristol-Myers Squibb

Matthew Van Wingerden General Manager Advanced Services Aktana

1:00pm – 1:15pm (EST)

Modernizing your field force starts with healthcare professionals

  • How RxVantage supported HCP needs to reconnect with life sciences during the pandemic
  • Move to help HCPs adapt to the next normal for life sciences engagement
  • How field teams can utilize HCP-led technology to optimize the way they engage

Alejandro Villageliu Executive Vice President Head of Enterprise RxVantage

1:15pm – 1:30pm (EST)

Build your team’s virtual engagement capability through new training, incentives, and tailored recruitment

  • Find out the implications of a hybrid communications model for your recruitment strategy
  • Prepare for a return to face-to-face communications and educate sales reps on successful balancing between virtual and in-person

Jeordan Legon Senior Director Digital Centre of Excellence Alnylam

1:30pm – 1:45pm (EST)

Thought leadership by ViiV Healthcare

Andrew Perry Vice President US Marketing ViiV Healthcare

1:45pm – 2:00pm (EST)

Live Q&A - Modernize your field teams and become healthcare partners

Jeordan Legon Senior Director Digital Centre of Excellence Alnylam

Andrew Perry Vice President US Marketing ViiV Healthcare

Alejandro Villageliu Executive Vice President Head of Enterprise RxVantage

Harmonize patient data for new patient understanding

2:00pm – 3:00pm (EST)

Personalize patient support by defragmenting the data landscape

  • Unify your platform approach across every patient touchpoint with your organisation to simplify information sharing and better inform decision-making
  • Boost external collaborative potential by developing platforms that allow greater interoperability between different partners and providers
  • Approaches to improve governance processes that ensure patient privacy and ease use to inform strategies

Dawn Steele Director of Patient Engagement GlaxoSmithKline

Saleem Hussaini Head of Patient Services IT Biogen

Jay Baucom Senior Vice President, Global Operations & CIO Alphanumeric

3:00pm – 3:15pm (EST)

Prove the value of support initiatives with new insight into patient journeys and outcomes using real-world evidence

  • How to overcome concerns around real-world data quality and convert internal laggards with definitive insight into business and patient value

Melissa Penn Deputy Director Advocacy Relations Bayer

3:15pm – 3:30pm (EST)

Remove barriers to patient participation and engagement by solving the privacy challenge

  • Develop privacy solutions so that data collection methods become burdenless and frictionless
  • Increase trust in the industry and empower patients by championing privacy with a more nuanced approach to consent

    Salesforce

3:30pm – 3:45pm (EST)

Thought leadership by Sanofi

Melissa Dupont Patient Engagement Lead Sanofi

3:45pm – 4:00pm (EST)

Live Q&A - Harmonize patient data for new patient understanding

Melissa Penn Deputy Director Advocacy Relations Bayer

Melissa Dupont Patient Engagement Lead Sanofi

    Salesforce

Pharma Only
Marketing and Commercial:
Roundtable

4:00pm – 5:00pm (EST)

Thought leadership by Doximity

Description tbc

    Doximity

Pharma Only
Market Access and RWE:
Workshop

4:00pm – 5:00pm (EST)

Real-World Data and AI for Strategy & Analytics

  • Learn how RWD and AI are being used to transform research, access, and value programs
  • Improve strategy and decision making based on advanced analytics and real-world outcomes
  • Explore real-world case examples applying RWD & AI today

Richard Gliklich, MD CEO OM1

Joseph Zabinski Senior Director, AI & Precision Medicine OM1

Pharma Only
Patient Engagement:
Workshop

11:00am – 12:00pm (EST)

Augmented Pharma - How AI is transforming the pharmaceutical industry

  • Healthcare is becoming more and more patient-centric each day - for the pharmaceutical industry specifically, patient centricity heightens competition with Big Tech companies that have already shown their ability to build trust with customers by centering on their needs.
  • Pharmaceutical companies can gain competitive advantage by innovating beyond creating new treatments and drugs. AI can be deployed powerfully to (a) accelerate R&D, (b) improve diagnosis, (c) strengthen the supply chain, (d) drive engagement and sales.
  • By building trust with patients and healthcare providers, streamlining IT operations and investing in AI, pharma companies will build a platform for ongoing innovation — and insulate themselves from competitive threats.

Jeff Headd Senior Director Commercial Data Sciences Janssen

Victor Bondarev Manager Operations and Insight Strategy Janssen

Martin Nanni Vice President Tech US Globant

Trish Martin Business Hacking Studio Director Globant

Pharma Only
Medical Affairs:
Roundtable

2:00pm – 3:00pm (EST)

Drive measurable outcomes from KOLs to optimize engagement strategy

  • Leverage verifiable global data to identify, understand and validate exactly who is right for what you need at any stage of engagement development.
  • Create a channel for all KOL related information to ensure cross functional and organizational optimization.
  • Cut through the noise of social media to drive improved engagement

Robert Consalvo Director of Strategic Commercial Engagement H1

Steven Bio Customer Strategy & Engagement Lead H1

Pharma Only
Patient Engagement:
Roundtable

3:00pm – 4:00pm (EST)

Is real time, real world evidence possible? How peer to peer support is enabling deeper insights into the patient journey

In a world with fewer in-person interactions, learn how branded peer support platforms are making it possible to gather real world evidence in real time while driving optimal adherence and improving outcomes with targeted outreach and behavioural nudges.

    Curatio